Maravai Lifesciences Holdings (MRVI) Amortizatization of Intangibles (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) recorded quarterly Amortizatization of Intangibles of $1.6 million in Q1 2026, down 29.81% quarter-over-quarter from $2.3 million in Q4 2025, and down 77.16% on a YoY basis from $7.0 million in Q1 2025.
Maravai Lifesciences Holdings (MRVI) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 77.16% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $11.1 million (down 48.61% YoY), while the FY2025 annual figure was $9.0 million, up 5.67% from the prior year.
- Amortizatization of Intangibles was $1.6 million for Q1 2026 at Maravai Lifesciences Holdings, down from $2.3 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $7.0 million in Q1 2025 to a low of $600000.0 in Q2 2025.
- Historically, Amortizatization of Intangibles has averaged $4.0 million across 5 years, with a median of $5.5 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Amortizatization of Intangibles soared 785.71% in 2023, then tumbled 90.32% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $6.2 million in 2022, then grew by 10.15% to $6.9 million in 2023, then sank by 68.58% to $2.2 million in 2024, then climbed by 6.02% to $2.3 million in 2025, then decreased by 29.81% to $1.6 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $1.6 million (Q1 2026), $2.3 million (Q4 2025), and $6.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 743.11 Mn | 734.71 Mn | 33.70 Mn | 1.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.61 Mn |
| Mar 31, 2026 | 1.61 Mn |
| Dec 31, 2025 | 2.29 Mn |
| Dec 31, 2025 | 2.29 Mn |
| Sep 30, 2025 | 6.60 Mn |
| Sep 30, 2025 | 6.60 Mn |
| Jun 30, 2025 | 600,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Mar 31, 2025 | 7.03 Mn |
| Mar 31, 2025 | 7.03 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Sep 30, 2024 | 6.20 Mn |
| Sep 30, 2024 | 6.20 Mn |
| Jun 30, 2024 | 6.20 Mn |
| Jun 30, 2024 | 6.20 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Dec 31, 2023 | 6.87 Mn |
| Dec 31, 2023 | 6.87 Mn |